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H U M A N  G E N E T I C S
Transcriptome and regulatory maps of decidua-derived 
stromal cells inform gene discovery in preterm birth
Noboru J. Sakabe1*, Ivy Aneas1*, Nicholas Knoblauch1, Debora R. Sobreira1, Nicole Clark2, 
Cristina Paz1, Cynthia Horth1, Ryan Ziffra1, Harjot Kaur1, Xiao Liu1, Rebecca Anderson1, 
Jean Morrison1†, Virginia C. Cheung3, Chad Grotegut4, Timothy E. Reddy5, Bo Jacobsson6,7, 
Mikko Hallman8, Kari Teramo9, Amy Murtha10‡, John Kessler3, William Grobman11, Ge Zhang12, 
Louis J. Muglia12§, Sarosh Rana13, Vincent J. Lynch1||, Gregory E. Crawford2, Carole Ober1,13¶**, 
Xin He1¶**, Marcelo A. Nóbrega1¶**
While a genetic component of preterm birth (PTB) has long been recognized and recently mapped by genome-wide 
association studies (GWASs), the molecular determinants underlying PTB remain elusive. This stems in part from 
an incomplete availability of functional genomic annotations in human cell types relevant to pregnancy and PTB. 
We generated transcriptome (RNA-seq), epigenome (ChIP-seq of H3K27ac, H3K4me1, and H3K4me3 histone modifi-
cations), open chromatin (ATAC-seq), and chromatin interaction (promoter capture Hi-C) annotations of cultured 
primary decidua-derived mesenchymal stromal/stem cells and in vitro differentiated decidual stromal cells and 
developed a computational framework to integrate these functional annotations with results from a GWAS of gesta-
tional duration in 56,384 women. Using these resources, we uncovered additional loci associated with gestational 
duration and target genes of associated loci. Our strategy illustrates how functional annotations in pregnancy-relevant 
cell types aid in the experimental follow-up of GWAS for PTB and, likely, other pregnancy-related conditions.
INTRODUCTION
Spontaneous preterm birth (PTB), defined as spontaneous labor 
and birth before 37 weeks of gestation, is associated with considerable 
infant mortality and morbidity, as well as long-term health conse-
quences into adulthood (1). A genetic component to PTB has long 
been recognized, but the significant role of environmental factors 
and the etiologic heterogeneity of birth before 37 weeks (2–4) have 
made it challenging to discover genetic associations and causal genes. 
For example, recent genome-wide association studies (GWASs) of 
gestational duration in 43,568 women (3331 with a preterm delivery) 
(5) and in 84,689 infants (4775 born preterm) (6) reported six and 
one genome-wide significant associations, respectively, with gestational 
duration considered as a continuous variable. Three loci were also 
associated with PTB (defined as a categorical variable of birth) in the 
maternal GWAS (5), but no loci were associated with PTB in the infant 
GWAS (6). These studies highlight the challenges of such complex and 
multifactorial phenotypes and the need for additional approaches to facil-
itate discovery of genes contributing to gestational duration and PTB.
Integrating GWAS that results with genomic and epigenomic 
annotations is a promising approach for assigning function to variants 
discovered by GWAS, as well as for identifying additional associa-
tions that do not reach stringent genome-wide significance threshold 
(7, 8). While large consortia [e.g., ENCODE (Encyclopedia of DNA 
Elements) (9), GTEx (Genotype-Tissue Expression Project) (10), 
and Roadmap Epigenomics (11)] have generated annotations of puta-
tive functional elements and genetic variants for many human cell 
types and tissues, there is a remarkable absence in these databases 
for the cell types and tissues that are relevant to pregnancy in general 
and to PTB in particular. Because the regulation of transcription has 
strong cell type–specific components and because annotations in 
disease-relevant tissues or cells tend to be most enriched among 
GWAS signals for those specific diseases (10, 12), follow-up studies 
of GWASs of pregnancy-associated conditions have been disadvan-
taged compared to most other complex diseases due to the paucity 
of functional annotations in cells relevant to pregnancy. To fill this 
gap in knowledge, we characterized the transcriptional and chro-
matin landscapes of cultured mesenchymal stromal/stem cells 
(MSCs) collected from human placental membranes and decidualized 
MSCs, also known as decidual stromal cells (DSCs). These cells play 
critical roles in promoting successful pregnancy, interfacing with fe-
tal cells throughout pregnancy, and the timing of birth (13, 14). We 
then built a computational framework that integrated these decidua- 
derived stromal cell annotations with the results of a large GWAS 
of gestational duration to facilitate discovery of PTB genes.
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This integrated analysis revealed a significant enrichment of heri-
tability estimates for gestational duration in decidua-derived stromal 
cell genomic regions marked by open chromatin or histone marks. 
Leveraging those functional annotations in a Bayesian statistical 
framework, we discovered additional loci associated with gestational 
duration and improved fine mapping in regions associated with 
gestational duration. Last, using promoter capture Hi-C (pcHi-C), 
we linked functionally annotated gestational age-associated variants 
to their putative target genes. More generally, these functional 
annotations should prove a valuable resource for studying other 
pregnancy-related conditions, such as preeclampsia and recurrent 
miscarriage, as well as conditions associated with endometrial dys-
function, such as endometriosis and infertility.
RESULTS
Generation of transcriptome and epigenome maps 
of untreated (MSC) and in vitro differentiated DSCs
Decidualization is the process of transformation of endometrial MSCs 
into DSCs that is induced by progesterone production that begins 
during the luteal phase of the menstrual cycle and then increases 
throughout pregnancy when successful implantation occurs [re-
viewed in (15)]. Using progesterone and estrogen or cyclic adenosine 
5′-monophosphate (cAMP) to induce decidualization of MSCs in 
culture has been used in cells derived from endometrial biopsies in 
nonpregnant women to characterize their transcriptomes and epi-
genomes and to identify genes and molecular pathways involved in 
this process (16–21).
Because obtaining endometrial cells in nonpregnant women 
through biopsies requires an invasive procedure that carries some 
risk and MSCs can also be obtained from human placentas (22–24), 
we isolated these cells from the decidua parietalis of three women 
who had delivered at term and established one primary MSC line 
from each to model the process of decidualization (see Materials 
and Methods). Briefly, cells were treated with medroxyprogesterone 
acetate (MPA) and cAMP for 48 hours, and a paired set of untreated 
samples was cultured in parallel for 48 hours. Three replicates of 
treated/untreated sets of each cell line were studied to assess exper-
imental variability in the two conditions. Each of the 18 samples 
(3 individual lines × 3 replicates × 2 conditions) were assayed to gen-
erate transcriptome [RNA sequencing (RNA-seq)], open chromatin 
[assay for transposase-accessible chromatin sequencing (ATAC-seq)], 
and histone modification [chromatin immunoprecipitation sequenc-
ing (ChIP-seq)] maps. A summary of those data is shown in table S1, 
and a representative example of the full set of annotations for one 
primary cell line is shown in Fig. 1. The number of reads generated 
for each sample in each condition and other descriptive data are 
provided in data file S1.
Robust gene expression changes occur in decidualized 
stromal cells
Analysis of the RNA-seq data using DESeq2 (25) revealed 1135 dif-
ferentially expressed genes after decidualization (table S1). Genes 
with decreased expression after 48 hours of treatment were highly 
enriched for cell cycle genes (data file S2), consistent with observa-
tions from endometrial biopsies from nonpregnant women that 
decidualization is associated with cell cycle arrest (19, 26). Genes 
with increased expression after treatment were enriched for insulin- 
related terms, also consistent with previous results from endometrial 
biopsies (26), and for glucose metabolism (18).
Fig. 1. Schematic of RNA-seq, ATAC-seq, ChIP-seq, and pcHi-C maps centered on the prolactin (PRL) gene, as an example. Each histone modification and RNA-seq 
track shows read counts per base pair for each experiment. The pcHi-C signal track shows the number of reads per MboI restriction fragment. Arcs in the pcHi-C interactions 
track show significant interactions between the promoter of the PRL gene and putative distal regulatory elements identified with pcHi-C. Pooled data (three replicates) 
for one cell line are shown for untreated cells (MSCs, in green) and decidualized cells (DSCs, in purple). pcHi-C data were generated in a fourth cell line that was decidualized.
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Identification of regulatory elements associated 
with decidualization
To identify putative regulatory elements in MSCs and DSCs, we as-
sayed H3K27ac, H3K4me1, and H3K4me3 histone modifications, 
which are markers of active enhancers, poised enhancers, and active 
promoters, respectively [reviewed in (27)]. We also used ATAC-seq 
to identify open chromatin regions to complement ChIP-seq data. 
To identify regulatory regions that might be altered in response to, 
and potentially regulate decidualization, we compared read counts 
of ATAC-seq and ChIP-seq peaks in untreated and decidualized cells, 
revealing tens of thousands of regions that differed between un-
treated and treated samples (table S1). Most of the differential peaks 
were marked with H3K27Ac and H3K4me1, indicating that the epi-
genetic changes underlying alterations in gene expression during 
decidualization predominantly occur in distant regulatory elements, 
such as enhancers.
We observed a moderate degree of overlap between the differential 
peaks across ATAC-seq and ChIP-seq data, with the two enhancer 
marks, H3K27ac and H3K4me1, showing the most overlap (Fig. 2A). 
In addition, putative regulatory regions that showed chromatin 
changes in response to decidualization were associated with genes 
whose expression also changed in response to decidualization (Fig. 2B). 
Regulatory regions with increased read counts clustered around genes 
that were more highly expressed after decidualization, indicating in-
creased chromatin accessibility or activation of enhancers of those 
genes. Conversely, genes that were more lowly expressed after 
decidualization were enriched for enhancers that became less acces-
sible or active. These observations indicate that the differential peaks 
of open chromatin and histone marks observed after decidualization 
correspond to regulatory elements that become more or less active, 
resulting in correlated gene expression changes of the nearby genes.
Previous work identified transcription factors that play critical roles 
in decidualized stromal cells (28–32). Several of the DNA binding motifs 
that were enriched in peaks with increased or decreased read counts in 
our data correspond to transcription factors previously implicated 
in decidualization (Fig. 2C), such as CAAT-enhancer binding protein 
(CEBP) (33), progesterone receptor (PGR) (28) that shares the same 
motif with androgen response element, and glucocorticoid receptor, 
FOSL2 (Fos-related antigen 2) (28), that shares the same motif with Fra1 
(Fos-related antigen 1), Atf3 (Activating transcription factor 3), and 
BATF (basic leucine zipper ATF-like transcription factor), and TEA 
(transcriptional enhancer factor)  domain transcription factors (21, 34). 
Whereas CEBP and PGR were exclusively enriched in peaks with 
increased read counts in decidualized cells, the FOSL2 motif was present 
in peaks that both changed positively and negatively in decidualized cells.
To better understand the role of these transcription factors in decid-
ualization, we obtained publicly available ChIP-seq data for PGR (28) 
and FOSL2 (28) from endometrial biopsies and analyzed the colocaliza-
tion of their binding locations with the putative regulatory elements 
identified by ATAC-seq and ChIP-seq identified in our study (Fig. 2B). 
We additionally analyzed FOXO1 (Forkhead box O1) (29), NR2F2 
(nuclear receptor subfamily 2 group F member 2) (30), and GATA2 
(GATA binding protein 2)  (31) ChIP-seq data because these transcrip-
tion factors have also been implicated in decidualization (29–31). With 
the exception of FOSL2, the colocalization enrichments of PGR, FOXO1, 
GATA2, and NR2F2 with ATAC-seq and ChIP-seq peaks were higher 
(9 to 16 folds) among peaks that were increased in decidualized cells 
(more open chromatin or increased histone modification levels) 
compared to all peaks (7.5 to 12.8 folds) and to peaks that decreased in 
decidualized cells (2 to 5 folds). This observation supports the notion 
that these transcription factors are involved in regulation of decidualization 
(28–31, 35). Although FOSL2 has been reported as a positive coregulator 
of PGR (28), the presence of FOSL2 motifs in peaks that both increased 
and decreased in decidualized cells (Fig. 2C) and the lack of difference in 
the colocalization enrichment between these two sets of peaks (Fig. 2D) 
suggests that FOSL2 may have a dual role in decidualization.
Together, our results support a model of decidualization that in-
volves changes in the regulatory landscape during the differentiation 
of MSCs into DSCs, including alterations in chromatin accessibility 
and in the activation levels of distant regulatory elements, accompa-
nied by the differential binding of key transcription factors, resulting 
in increases or decreases in gene expression.
Chromatin interactions aid in the identification of target 
genes of distal regulatory elements
As shown in Fig. 2B, the surrounding regions of differentially ex-
pressed genes were enriched for differential ChIP-seq and ATAC-
seq peaks that changed in the same direction as the genes in decidu-
alized samples. Accordingly, when we paired differential peaks with 
the nearest expressed gene as its putative gene target, we observed 
that these pairs were more likely to have matching directions of 
change (i.e., both the peak and the gene have increased or decreased 
read counts in decidualized samples) than nonmatching directions 
when compared with pairs that were assigned randomly (Fig. 3A).
In many cases, however, the target gene for a regulatory element 
is not the nearest gene (36), and therefore, information about distal 
chromatin interactions can be useful in prioritizing candidate gene 
targets of variants identified in GWAS. To this end, we generated a 
pcHi-C map of a decidualized cell line, thus enriching for the iden-
tification of long-range chromatin interactions between promoters 
and distant regulatory elements (37–39). We identified a total of 
161,337 interactions, of which 53,211 were between promoters and 
distal regions of accessible chromatin assayed by ATAC-seq and 
ChIP-seq, suggestive of their regulatory role. We used the significant 
interactions between promoters and distal regions that we identified 
to pair differential peaks with putative target genes. As shown in 
Fig. 3A, using pcHi-C interactions as a pairing method resulted in 
enhanced identification of differential peak/differential target gene 
pairs that have matching directions of change compared to random 
assignment of gene-target pairs.
Whereas assigning peaks to the nearest expressed gene also led 
to enhanced assignment of differential peaks to target genes with 
matching directions of change (Fig. 3A), pcHi-C was helpful in 
identifying less obvious target genes, as shown in Fig. 3B. In this 
example, several pcHi-C interactions link distal regulatory elements 
up to 847 kb away that became more active in decidualized cells to 
the promoter of a gene (FOXO1) that was up-regulated in decidual-
ized cells and is known to be involved in decidualization (32). The 
nearest expressed gene method assigned those differential peaks to 
COG6, a gene that does not change expression in decidualized samples 
and is therefore a less likely target.
In conclusion, by combining pcHi-C interactions with the epi-
genome maps and transcriptome data, we were able to identify 
genes and putative regulatory elements that respond to, or regulate, 
the decidualization process. We next used these functional 
genomic maps and datasets to fine map GWAS loci for gestational 
duration and identify new candidate genes with a potential 
role in PTB.
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Fig. 2. Differential histone modification and ATAC-seq peaks are associated with differential expression and enriched for transcription factors with roles in 
decidualization. (A) Plot showing the overlap between the different histone modifications and ATAC-seq maps (intersection between annotations). Peaks were assigned 
to 100-bp bins to avoid ambiguity in overlap due to different peak borders. Black circles indicate overlap with other annotations; light gray circles indicate that the anno-
tation does not overlap others. (B) Each data point shows the ratio between the number of increased/decreased differential peaks nearby genes that increase expression 
after decidualization (blue, positive log ratios; upper half of the figure) or decrease expression after decidualization (orange, negative log ratios; lower half of the figure). 
Genes that were more highly expressed in decidualized cells were flanked by a higher number of ChIP-seq and ATAC-seq peaks that displayed increased read counts in 
decidualized samples compared to peaks that displayed decreased read counts (top inset). Genes that were down-regulated in decidualized cells showed the opposite 
trend (bottom inset). All enrichments: P < 10−25. (C) DNA binding motifs of transcription factors relevant in decidualization are enriched in peaks that change following 
decidualization treatment. Motifs are color-coded by similarity. (D) Colocalization of PGR, FOSL2, FOXO1, GATA2, and NR2F2 with ATAC-seq and ChIP-seq peaks. Tran-
scription factor binding sites co-occur with ATAC-seq and ChIP-seq peaks in both untreated (green) and decidualized (purple) cells more often than with random peaks. 
Enrichment of the co-occurrences of PGR, FOXO1, GATA2, and NR2F2 are higher when co-occurring with peaks that have increased read counts (navy blue) and lower 
with peaks that have decreased read counts (orange) in decidualized compared to untreated cells. Enrichment of co-occurrences with peak sets was calculated as the fold 
difference between the number of transcription factor peaks overlapping with ATAC-seq/ChIP-seq peaks and with a random set of peaks (see Materials and Methods).
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The heritability of gestational duration is enriched 
for functional annotations in DSCs
To identify candidate genes that may play a role in gestational dura-
tion and PTB, we used summary data from a GWAS of gestational 
duration based on a meta-analysis of a 23andMe GWAS (n = 42,121) 
(5) and the results from six European datasets (n = 14,263). A de-
tailed description of the GWAS is in the Supplementary Materials 
and figs. S1 and S2. After filtering for single-nucleotide polymorphism 
(SNPs) that are present in the 1000 Genomes Project data and minor 
allele frequency of >0.01, we identified SNPs at six autosomal loci, 
defined as approximately independent blocks by LDetect (40), that 
were associated with gestational duration at genome-wide signifi-
cance of P < 5 × 10−8 (table S2). We then created a computational 
pipeline to assess enrichment of GWAS signals in functional anno-
tations that we generated in untreated (MSCs) and decidualized (DSCs) 
stromal cells to fine map GWAS loci and discover candidate causal 
genes and to potentially provide support for additional loci that did 
not reach genome-wide significance in the GWAS (Fig. 4A). Each 
step of this procedure is explained below and described in details in 
Materials and Methods.
We first used stratified linkage disequilibrium (LD) score regression 
(S-LDSC) (41) to assess enrichment of GWAS signals in functional 
annotations in endometrial stromal cells. S-LDSC takes as input 
GWAS summary statistics across the genome and functional anno-
tations of SNPs, e.g., whether an SNP is in ATAC-seq peak, and re-
turns as output heritability enrichment of each annotation. S-LDSC 
is a commonly used tool for estimating the proportion of heritability 
of complex phenotypes that is explained by variants in certain func-
tional annotations. The heritability enrichment is defined by the 
proportion of heritability explained by annotations divided by the 
expected proportion, which is the percent of SNPs genome wide that 
are in these functional annotations. To account for possible systematic 
bias in this analysis, i.e., SNPs within annotations of interest may 
differ from background SNPs in systematic ways such as their LD 
structure and epigenomic properties, we included a range of baseline 
annotations (default S-LDSC setting), including LD-related anno-
tations, deoxyribonuclease (DNase) hypersensitivity, enhancer 
annotation, H3K27ac, H3K4me1, and other histone marks (the union 
across cell types). Thus, if an annotation is shared by many cell 
types, then it would not show the enrichment in S-LDSC analysis 
(see Materials and Methods).
Using S-LDSC, we found 5- to 10-fold enrichments of GWAS 
heritability for gestational duration in our functional annotations 
compared to the baseline model of S-LDSC (Fig. 4). The enrichment 
Fig. 3. pcHi-C connects predicted regulatory elements to their putative target genes. (A) Randomly assigning a gene to a peak (see Materials and Methods) resulted 
in fewer peaks that matched the direction of change with that of differentially expressed genes than when using pcHi-C interactions or the nearest gene to pair peaks to 
genes. (B) The FOXO1 gene is more highly expressed in decidualized samples (fourfold increase, P = 7 × 10−22) and its promoter physically interacts (red arcs) with distal 
regulatory elements (yellow highlights) that show increased activation in decidualized samples. The nearest expressed gene to these differential peaks is COG6.







Sakabe et al., Sci. Adv. 2020; 6 : eabc8696     2 December 2020
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
6 of 15
of enhancer marks H3K27ac and H3K4me1 was higher in decidual-
ized than in untreated cells, but the opposite pattern was observed 
for the promoter mark H3K4me3, which was more enriched in un-
treated (MSCs) than in decidualized (DSCs) cells. These findings 
are consistent with previous observations that enhancers are often 
more dynamic and condition- or tissue-specific than promoters (10). 
We observed weaker heritability enrichments of open chromatin 
regions defined by ATAC-seq and of interaction regions in pcHi-C. 
However, because we performed joint analysis of all annotations 
together, the enrichment of one annotation (e.g., ATAC-seq peaks) 
will be reduced if the enrichment is partially explained by other, 
overlapping annotations (e.g., H3K27ac). Although the promoter 
mark H3K4me3 in untreated cells showed the highest enrichment, 
the annotations that contributed most to the heritability of gestational 
duration were enhancers (Fig. 4) due to the much larger number of 
enhancer histone marks than promoters in the genome. Our results 
thus highlight the importance of functional annotations in endo-
metrial stromal cells at GWAS loci for gestational duration.
Integrated analysis of GWAS and decidual cell functional 
annotations improves fine mapping of causal variants 
of gestational duration and identifies putative target genes
We next developed a computational procedure, based on fine mapping, 
to integrate the decidua stromal cell functional maps with a GWAS 
of gestational duration to identify putative causal variants (Fig. 4A). 
Because of extensive LD in the human genome, the causal variants 
driving the associations are unknown at most loci discovered by 
GWAS. Fine mapping is a Bayesian statistical procedure that takes as 
input GWAS summary statistics and patterns of LD at trait-associated 
loci and computes the probability of each variant at a locus to be a 
Fig. 4. GWAS analysis pipeline and heritability enrichment in functional annotations. (A) Computational pipeline for analyzing GWAS of gestation duration. Yellow 
boxes (input data): GWAS summary statistics and functional annotations from endometrial stromal cells (in both untreated and decidualized cells). Green boxes: Stages 
of statistical analysis (see Materials and Methods). (B) Stratified LDSC heritability analysis of GWAS of gestational duration using functional annotations. Left: Fold enrichment 
of heritability in each annotation. Dashed line shows values at 1, i.e., no enrichment. Center: Proportion of heritability explained by each annotation. Right: Proportion of 
SNPs across the genome that fall within an annotation. For each annotation, enrichment (left) is the ratio of h2 proportion (center) divided by the SNP proportion (right). 
Error bars represent 95% confidence intervals.
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causal variant (7). These probabilities, known as posterior inclusion 
probabilities (PIPs), reflect our confidence of certain SNPs being 
causal variants. The PIP of a variant ranges from 0 to 1, with 1 indi-
cating full confidence that the SNP is a causal variant. If a region 
contains a single causal variant, the PIPs of all SNPs in the region 
should approximately sum to 1.
While fine mapping has been commonly used in identifying pu-
tative causal variants from GWAS of complex traits (7), it is often 
difficult to narrow down causal signals to one or a small number of 
variants in most GWAS loci. Standard fine mapping treats all SNPs 
at a locus equally. Recent work suggests that incorporating Bayesian 
prior probabilities that favor functional SNPs improves fine mapping 
(8, 42). We posited that integrating functional annotations in 
pregnancy-relevant cells in a statistical fine-mapping framework 
would aid in (i) identifying candidate causal variants at each locus 
associated with gestation duration, (ii) linking those variants to their 
target genes, and (iii) discovering additional loci and genes associated 
with gestational duration that may have failed to reach the stringent 
threshold for significance in GWAS.
We first leveraged the enrichments of DSC annotations to create 
Bayesian prior probabilities for a variant being causal. On the basis 
of the results of S-LDSC, we chose H3K27ac, H3K4me1, and pcHi-C 
interactions from the decidualized cells, and H3K4me3 from un-
treated cells, as functional genomic annotations to create informa-
tive priors using TORUS (42). TORUS takes as input genome-wide 
summary statistics from GWAS and the functional annotations of 
SNPs and computes enrichment parameters of annotations, which 
reflect how much more likely an SNP is a causal variant than ran-
domly chosen SNPs (table S3). SNPs associated with functional 
annotations are generally assigned higher prior probabilities. In ad-
dition, TORUS computes statistical evidence at the level of genomic 
blocks, defined as the probability that a block (determined by LD) 
contains at least one causal SNP. Without including any histone marks 
or chromatin accessibility annotations, TORUS implicated six 
autosomal blocks in the genome at false discovery rate (FDR) of < 0.05, 
including five of the six genome-wide significant autosomal loci 
identified in the GWAS (P < 5 × 10−8). One locus on chromosome 3 
had an FDR = 0.11 and was therefore not identified by TORUS, and 
one locus on chromosome 9 that was not identified in the GWAS 
was implicated by TORUS (data file S3). By including the functional 
genomic annotations from endometrial stromal cells, the number 
of high confidence blocks increased to 10, including all 6 that were 
significant in the gestational duration GWAS and 4 that were not 
significant in the GWAS (data file S3).
We next performed computational fine mapping on these 10 blocks, 
with the informative priors learned by TORUS, using sum of single 
effects (SuSiE) regression (43). Conceptually, SuSiE is a Bayesian 
version of the stepwise regression analysis commonly used in GWAS 
(i.e., conditioning on one variant and testing if there is any remain-
ing signal in a region). SuSiE accounts for the uncertainty of causal 
variants in each step and reports the results in the form of PIPs. 
Including the priors defined by TORUS using DSC functional an-
notations significantly improved fine mapping (Fig.  5A, table S3, 
and data file S4). For example, only one SNP reached PIP  >  0.3 
across all 10 blocks using the default setting under SuSiE (uniform 
prior, treating all SNPs in a block equally). This reflects the general 
uncertainty of pinpointing causal variants due to LD, e.g., a strong 
GWAS SNP in close LD with nine other SNPs would have PIP 
about 0.1. By using the annotation-informed priors, eight SNPs in 
six different blocks reached PIP > 0.3 (Fig. 5A). In some blocks, we 
were able to fine-map a single high-confidence SNP, e.g., the FOXL2 
locus on chromosome 3, while in other blocks, we had considerable 
uncertainty of the causal variants, as shown by large credible sets, i.e., 
the minimum set of SNPs to include the causal SNP with 95% prob-
ability (Fig. 5B). Table 1 summarizes the most probable causal 
variants in eight blocks (fine mapping in the remaining two blocks 
produced large credible sets with no high-PIP SNPs) and their likely 
target genes based on promoter assignment or chromatin interac-
tions from pcHi-C. We note that our results of the WNT4 locus 
identified rs3820282 as the likely causal variant. This is consistent 
with our previous results demonstrating experimentally that the T 
allele of this SNP disrupts the binding of estrogen receptor 1 (5). 
This SNP was among the three most likely SNPs in our fine-map-
ping study, with a PIP of 0.27 (Table 1).
We highlight the results from two regions. In both cases, we were 
able to identify putative risk genes with relatively high confidence, 
and neither is the nearest gene of lead SNPs in GWAS. In the first case, 
two adjacent SNPs [311–base pair (bp) apart], rs13141656 and rs7663453, 
on chromosome 4q34 did not reach genome-wide significance in 
the GWAS (P = 3.9 × 10−7 and 4.5 × 10−7, respectively). After using 
functional annotations in decidua-derived stromal cells, the block 
containing these SNPs was highly significant (TORUS q = 0.02), sug-
gesting the presence of at least one causal variant in this block. The 
two SNPs together explained most of the PIP signal in the block 
(PIP 0.38 and 0.33, respectively, Table 1). The two SNPs are located 
in a region of open chromatin in endometrial stromal cells, with 
enhancer activity marked by both H3K27ac and H3K4me1 (Fig. 5C). 
Only 9 of the 129 tissues from the Epigenome Roadmap (11) also had 
H3K27ac, H3K4me1, or H3K4me3 peaks spanning the rs13141656 
locus and only 2 spanning the rs7663453 locus. In addition, this 
putative enhancer is bound by multiple transcription factors, includ-
ing GATA2, FOXO1, NR2F2, and PGR, based on ChIP-seq data. 
The only physical interaction of this enhancer in the pcHi-C data in 
decidualized stromal cells is with the promoter of the HAND2 gene, 
located 277 kb away (Fig. 5C). Summing over the PIPs of all SNPs 
whose nearby sequences interact with HAND2 (heart and neural 
crest derivatives expressed 2) via chromatin looping gives an even 
higher probability, 0.89, suggesting that HAND2 is very likely to be 
the causal gene in this region (table S4). HAND2 is an important 
transcription factor that mediates the effect of progesterone on uterine 
epithelium (44). Thus, in this example, we identified a previously 
unknown locus, the likely causal variant(s), the enhancers they act on, 
and an outstanding candidate gene for gestational duration and PTB.
The second example focuses on the locus showing a strong GWAS 
association with gestational duration on chromosome 3q21. The lead 
SNP, rs144609957 (GWAS P = 4 × 10−13), is located upstream of the 
EEFSEC (eukaryotic elongation factor, selenocysteine-tRNA–specific) 
gene. There is considerable uncertainty of the causal variants in this 
region, with 50 SNPs in the credible set and the lead SNP explaining 
only a small fraction of signal (PIP = 0.02). Among all 12 SNPs with 
PIP > 0.01, 11 have functional annotations, most commonly H3K4me1 
and pcHi-C interactions. For nine SNPs (first three shown in Table 1), 
the sequences in which they are located physically interact with the 
promoter of GATA2 in the pcHi-C data but not with any other pro-
moters in the region (fig. S3). The PIPs of all SNPs in the genomic 
regions that likely target GATA2 through chromatin looping sum to 
0.68 (table S5). Thus, despite uncertainty of causal variants in this 
region, our results implicate GATA2 as a candidate causal gene in 
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Fig. 5. Fine-mapping GWAS loci of gestational duration. (A) PIPs of SNPs using uniform vs. functional priors in SuSiE (each dot is an SNP). The functional prior of an SNP 
is based on SNP annotations and is estimated using TORUS. (B) Summary of fine-mapping statistics of all 10 regions. X axis: The size (number of SNPs) of credible set. Y axis: 
The maximum PIP in a region. We label each region by its top SNP (by PIP) and the likely causal gene, according to Table 1 or the nearest gene of the top SNP. (C) Likely 
causal variants near HAND2 and their functional annotations. The top panel shows the significance of SNP association in the GWAS and the middle panel shows fine-mapping 
results (PIPs) in the region. The vertical yellow bar highlights the two SNPs with high PIPs. These SNPs are located in a region annotated with ATAC-seq, H3K27ac, 
H3K4me1, and H3K4me3 peaks (bottom). This putative enhancer also had increased ATAC-seq, H3K27ac, and H3K4me1 levels in decidualized samples and interacts with 
the HAND2 promoter (red arc).
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endometrial stromal cells. GATA2 is a master regulator of embryonic 
development and differentiation of tissue-forming stem cells (45). 
As support for the possible role of GATA2 in pregnancy, GATA2 
deficient mice show defects in embryo implantation and endometrial 
decidualization (35), making this another excellent candidate causal 
gene for gestational duration and PTB.
DISCUSSION
The molecular processes that signal the onset of parturition in human 
pregnancies, and how perturbation of those processes result in PTB, 
are largely unknown. Yet, understanding these processes would reveal 
important insights into the potential causes of adverse pregnancy 
outcomes, including spontaneous labor before 37 weeks’ gestation, 
and potentially lead to the identification of biomarkers and thera-
peutic targets for PTB. Although it is experimentally challenging to 
link decidualization processes directly to parturition in humans, it 
is well accepted that shallow implantation due to suboptimal decid-
ualization is associated with poor pregnancy outcomes in general 
(46–48) and that the decidua is key in triggering parturition (13, 14). 
Thus far, however, specific genes that perturb decidualization pro-
cesses and lead to PTB are poorly defined.
Unbiased GWASs do not require prior knowledge of molecular 
processes underlying disease phenotypes and have the potential to 
identify novel genes and pathways contributing to common diseases. 
However, the significant heterogeneity of most common diseases and 
small effects of most common disease-associated variants lead to the 
requirement for very large sample sizes (in the tens to hundreds of 
thousands of cases) to discover more than a handful of associated 
loci that meet stringent criteria for genome-wide significance. To 
address this limitation and provide orthogonal evidence for assess-
ment of associations, we characterized the transcriptional and chro-
matin landscapes in decidua-derived stromal cells and integrated those 
functional annotations with a GWAS of gestational duration to dis-
cover novel loci and genes. The primary motivation for these studies 
was the notable paucity of genomic and epigenomic functional anno-
tations in pregnancy-relevant primary cells among those studied by 
large consortia (9–11). Here, we filled a significant gap by providing 
maps in untreated and decidualized stromal cells and used these 
maps for annotating GWAS of pregnancy-related traits.
Table 1. Most probable SNPs identified from computational fine mapping of regions associated with gestational duration. Functional annotations are 
based on data from endometrial stromal cells. We list an annotation if the SNP is located in a sequence with that annotation in either untreated or decidualized 
condition. Functional prior is the prior probability of an SNP being a causal variant. For an SNP without any functional annotation, its prior probability is 3.6 × 
10−6. We list the pcHi-C annotation if the SNP is within 1 kb of a region involved in a pcHi-C interaction. We call a gene the target of an SNP if (i) the SNP is 
located in the promoter (< 1 kb of transcription start site) of that gene or (ii) the promoter of that gene has a pcHi-C interaction with a region within 1 kb of the 
SNP. In the case of rs147843771 at the FOXL2 locus, the target was defined by literature evidence (69). The number of credible SNPs at each region is shown in 
Fig. 5B. SNPs in bold are discussed in the text. FOXL2 (69), forkhead box L2; GATA2, GATA-binding protein 2; HAND2, heart and neural crest derivatives expressed 
2; KCNAB1, potassium voltage-gated channel subfamily A member regulatory beta subunit 1; WNT4, Wnt family member 4. 
SNP Location (hg19) GWAS P value Functional prior PIP Functional annotations Likely target
rs147843771 chr3:138843356 3.8 × 10−8 8.3 × 10−5 0.74 K4me1 FOXL2
rs17315501 chr3:139029676 1.7 × 10−7 9.9 × 10−5 0.21 K4me1, K4me3, ATAC, K27ac
rs2946164 chr5:157884706 3.0 × 10−26 8.3 × 10−5 0.72 K4me1





rs7663453 chr4:174729014 4.5 × 10−7 5.1 × 10−4 0.33 K4me1, K27ac, K4me3, pcHi-C HAND2 (pcHi-C)
rs13387174 chr2:74206685 4.7 × 10−7 3.8 × 10−4 0.35 pcHi-C, K4me1, K27ac WBP1 (pcHi-C)
rs13390332 chr2:74207357 2.0 × 10−7 9.9 × 10−5 0.18 K4me1, K27ac WBP1 (pcHi-C)
rs4677884 chr3:123062970 4.1 × 10−9 8.3 × 10−5 0.34 K4me1, ATAC
rs56318008 chr1:22470407 2.3 × 10−12 4.3 × 10−4 0.3 K4me1, K4me3, ATAC, pcHi-C WNT4 (promoter)
rs55938609 chr1:22470451 2.3 × 10−12 4.3 × 10−4 0.3 K4me1, K4me3, ATAC, pcHi-C WNT4 (promoter)
rs3820282 chr1:22468215 6.4 × 10−13 1.1 × 10−4 0.27 K4me1, K4me3, ATAC WNT4 (promoter)
rs4679761 chr3:155868039 5.0 × 10−9 9.9 × 10−5 0.24 K4me1, K27ac KCNAB1 (pcHi-C)
rs9882088 chr3:155867092 5.5 × 10−9 8.3 × 10−5 0.19 K4me1
rs3122173 chr3:127889287 5.4 × 10−12 3.2 × 10−4 0.18 K4me1, pcHi-C GATA2 (pcHi-C)
rs2999048 chr3:127878416 2.0 × 10−12 8.3 × 10−5 0.12 K4me1, K27ac, pcHi-C GATA2 (pcHi-C)
rs1554535 chr3:127895986 1.2 × 10−11 3.8 × 10−4 0.10 K4me1, pcHi-C, K27ac GATA2 (pcHi-C)
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We chose to focus these studies on endometrial stromal cells 
because of their central importance in both the establishment and 
maintenance of pregnancy, as well as their intimate juxtaposition to 
fetal trophoblast cells throughout pregnancy. Of particular relevance 
are the roles that decidualized stromal cells play in regulating tro-
phoblast invasion, modulating maternal immune and inflammatory 
responses at the maternal-fetal interface, and controlling remodeling 
of the endometrium (48). Defects in all of these processes have been 
considered a contributing factor to pregnancy disorders (48, 49). 
Moreover, we showed that the SNPs in regions with endometrial 
stromal cell functional annotations explained more of the heritability 
of gestational duration compared to just using baseline annotations. 
Among all annotations, enhancer marks H3K4me1 (in both decid-
ualized and untreated stromal cells) and H3K27ac (in decidualized 
cells) were 8- to 10-folds enriched at GWAS loci after adjusting for 
the general annotations and accounted for 50 to 70% of the GWAS 
heritability. The lack of complete independence between these marks 
makes it difficult to delineate their individual effects but, nonetheless, 
highlights the importance of enhancers and of gene regulation in 
endometrial stromal cells in modulating the effects of GWAS variants 
on gestational duration. This is consistent with both the known tissue- 
specific roles of enhancers and the observation that more than 90% 
of GWAS loci reside outside of the coding portion of the genome 
and are enriched in regions of open chromatin and enhancers (12, 41).
Integrating transcriptional and chromatin annotations of gene 
regulation from MSCs and DSCs improved our ability to discover 
novel GWAS loci and identify likely causal SNPs and genes associ-
ated with gestational duration. We illustrate how our integrated 
platform identified a novel causal locus and candidate gene (HAND2) 
associated with gestational duration, as well as refined the annota-
tion of loci that had been previously identified. Our data suggest 
that in endometrial stromal cells, GATA2 is likely the target gene of 
enhancers harboring SNPs associated with gestational duration. This 
does not exclude the possibility that the nearest gene to the associ-
ated SNPs, EEFSEC, may be a target gene in other cell types. Both 
HAND2 (50) and GATA2 (51) are involved in decidualization pro-
cesses in humans, and perturbations in this process have been linked 
to poor pregnancy outcomes (46–48). Neither GATA2 nor HAND2 
was identified as potential candidate genes in previous GWASs of 
gestational duration, or PTB supports our approach and the impor-
tance of using functional annotations from cell types relevant to 
pregnancy to fine map and identify candidate genes for the pregnancy- 
related traits. Overall, the integrated analyses performed in this study 
resulted in the identification of both novel GWAS loci and novel 
candidate genes for gestational duration, as well as maps of the regu-
latory architecture of these cells and their response to decidualization.
However, there are some limitations. Our results are based on 
cells from only three individuals, which may not fully capture the 
regulatory landscape of endometrial stromal cells. For pcHI-C, we 
used cells from a single individual to generate the chromatin inter-
actions map. Another limitation is that we focused on only one cell 
type, albeit one that plays a central role in pregnancy and only one 
exposure (hormonal induction of decidualization) at one time point 
(48 hours). Furthermore, it is unclear how our model of in vitro 
decidualization mimics the endogenous decidualization of endo-
metrial cells during pregnancy. While we chose decidualization as a 
perturbation to ascertain the dynamic features of functional genomic 
annotations, we fully anticipate that obtaining annotations in other 
cell types and in response to other relevant perturbations will im-
prove the ability to identify novel loci, variants, and genes associated 
with PTB. Future studies that include fetal cells from the placenta 
and uterine or cervical myometrial cells could reveal additional pro-
cesses that contribute to gestational duration and PTB, such as those 
related to fetal signaling and the regulation of labor, respectively. 
Inclusion of additional exposures, such as trophoblast conditioned 
media (52) and additional exposure times, may further reveal pro-
cesses that are pregnancy specific. Second, to maximize power, we 
focused on a GWAS of gestational duration and not PTB per se. 
While previous GWAS have shown that all PTB loci were among 
the gestational age loci (5), we realize that some of the loci that we 
identified could be related to normal variation in gestational duration 
and not specifically to PTB. Nonetheless, our findings contribute to 
our understanding of potential mechanisms underlying the timing 
of human gestation, about which we still know little. Last, although 
our ChIP-seq results revealed an association between GATA2 bind-
ing and decidualization, confirming the role of this transcription 
factor in decidual cell biology (53, 54), and studies in murines sup-
port its role in endometrial processes (35), we do not yet have direct 
evidence showing that perturbations in the expression of GATA2, 
or any of the other target genes identified, influence the timing of 
parturition in humans. Future studies will be needed to directly im-
plicate the expression of these genes in gestational duration or PTB. 
Our study highlights the importance of generating functional anno-
tations in pregnancy-relevant cell types to inform GWASs of 
pregnancy-associated conditions. Our results suggest that the expres-
sion of two transcription factors, GATA2 and HAND2, in endometrial 
stromal cells may regulate transcriptional programs that influence 
the timing of parturition in humans, which could lead to the identi-
fication of biomarkers of or therapeutic targets for PTB.
MATERIALS AND METHODS
Ethics statement
This study was approved by the Institutional Review Boards at the Univer-
sity of Chicago, Northwestern University, and Duke University Medical 
School. Informed consent for the use of data collected via questionnaires 
and clinics was obtained from participants following the recommendations 
of the ALSPAC (Avon Longitudinal Study of Parents and Children) Ethics 
and Law Committee at the time. Informed consent for the use of genetic 
data in the other six GWASs used in this study was also obtained from 
participants. Details are available in the Supplementary Materials.
Sample collections
Placentas were collected from three African American women (≥18 years 
old) who delivered at term (≥37 weeks) following spontaneous labor; 
all were vaginal deliveries of singleton pregnancies. Within 1 hour of 
delivery, 5 cm by 5 cm pieces of the membranes were sampled from a 
distant location of the rupture site. Pieces were placed in Dulbecco’s modi-
fied Eagle’s medium (DMEM)-Ham’s F12 media containing 10% fetal 
bovine serum (FBS) and 1% penicillin/streptomycin. Samples were kept at 
4°C and processed within 24 hours of tissue collection. This study was 
approved by the Institutional Review Boards at the University of 
Chicago, Northwestern University, and Duke University Medical School.
Isolation of mesenchymal stromal cells from human 
placental membranes
Third trimester placental tissue was enzymatically digested by a 
modification of previously described methods (55, 56). Decidua tissue 
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was gently scraped from chorion, and tissue was enzymatically 
digested in a solution (1× Hanks’ balanced salt solution, 20 mM 
Hepes, 30 mM sodium bicarbonate, and 1% bovine serum albumin 
fraction V) containing collagenase type IV (200 U/ml; Sigma-Aldrich, 
C-5138), hyaluronidase type IS (1 mg/ml; Sigma-Aldrich, H-3506), and 
DNase type IV (0.45 KU/ml, Sigma-Aldrich, D-5025) at 37°C, until 
a single-cell suspension was obtained (usually three rounds of 30 min 
digestion using fresh digestion media each round). Epithelial cells 
were removed by filtering through a 75 M nylon membrane and 
RPMI (Sigma-Aldrich) containing 10% FBS was added for enzyme 
inactivation. Dissociated cells were collected by centrifugation at 400g 
for 10 min and washed in RPMI/10% FBS. Erythrocytes were re-
moved by cell pellet incubation with 1× red blood cell lysis buffer 
(Sigma-Aldrich) for 2.5 min at room temperature. The resulting cells 
were counted and resuspended in seeding media [1× phenol red-free 
high-glucose DMEM (Gibco)] supplemented with 10% FBS (Thermo 
Fisher Scientific), 2 mM l-glutamine (Life Technologies), 1 mM 
sodium pyruvate (Fisher Scientific), 1× insulin-transferrin-selenium 
(ITS; Thermo Fisher Scientific), 1% penicillin/streptomycin, and 1× 
antibiotic-antimycotic (Thermo Fisher Scientific). Dissociated cells 
were plated into a T75 flask and incubated at 37°C and 5% CO2 for 15 to 
30 min (enrichment by attachment). The supernatant was carefully 
removed, and loosely attached cells were discarded. Plates were allowed 
to grow in fresh media containing 10% charcoal-stripped FBS (CS-FBS), 
and 1× antibiotic-antimycotic until the plate was 80% confluent. The 
antibiotic-antimycotic was removed from the culture media after 
2 weeks of culture. We obtained >99% vimentin-positive cells after three 
passages (fig. S4). Cells were expanded, harvested in 0.05% trypsin, and 
cryopreserved in 10% dimethylsulfoxide culture media for subsequent 
use. Each cell line was defined as coming from a different sample collec-
tion (different pregnancy).
Decidualization of mesenchymal stromal cells in vitro
Cells were plated and grown for 2 days in cell culture media (1× phenol 
red-free high-glucose DMEM, 10% CS-FBS, 2 mM l-glutamine, 1 mM 
sodium pyruvate, and 1× ITS). After 2 days, cells were treated either 
with control media (1× phenol red-free high-glucose DMEM, 2% CS-FBS, 
2 mM l-glutamine) or decidualization media (1× phenol red-free high- 
glucose DMEM, 2% CS-FBS, 2 mM % l-glutamine, 0.5 mM 8-Br-cAMP, 
and 1 M MPA) for 48 hours. Cells were incubated at 37°C and 5% CO2 
and harvested for ATAC-seq, ChIP-seq, and RNA-seq, and prolactin 
(PRL) and insulin-like growth factor-binding protein 1 (IGFBP1) 
mRNA were assessed by quantitative real-time polymerase chain 
reaction (PCR) before each downstream assay was performed.
RNA sequencing
Total RNA was extracted from approximately 1 million cells using 
the AllPrep DNA/RNA Kit (QIAGEN) according to manufacturer’s 
instructions. RNA quality (RNA integrity number) and concentration 
was assessed by Bioanalyzer 2100 (Agilent technology). RNA-seq 
libraries were generated by a TruSeq stranded total RNA library prep 
kit (Illumina) and TruSeq RNA CD Index Plate.
Chromatin immunoprecipitation sequencing
For ChIP experiments, cells were cross-linked by adding to the me-
dia 37% formaldehyde to a final concentration of 1%, gently mixed, 
incubated for 10 min, and quenched for 5 min with 2.5 M glycine 
for a final of 0.125 M per plate. Cells were washed using cold 1× 
phosphate-buffered saline and scraped in 15 ml of cold Farnham 
lysis buffer and protease inhibitor (Roche, 11836145001), and cell 
pellets were flash frozen and kept at −80°C. Thawed pellets were 
resuspended in radioimmunoprecipitation assay buffer on ice, ali-
quoted into 20 million cells per tube, and sonicated by Bioruptor 
(three 15-min rounds of 30 s ON, 30 s). ChIP was performed on 
10 million cells using antibodies to H3K27ac, H3K4me3, and H3K4me1 
histone marks (ab4729/lot no. GR274237, ab8580/lot no. GR273043, 
and ab8895/lot no. GR262515, respectively). M-280 sheep anti-rabbit 
immunoglobulin G Dynabeads (Invitrogen, 11203D) was used for 
chromatin immunoprecipitation. DNA was purified using the Qiagen 
MinElute PCR Purification Kit, quantified by Qubit, and prepared 
for sequencing using the Kapa Hyper Prep Kit. All libraries were 
pooled to 10 nM per sample before sequencing.
Assay for transposase-accessible chromatin sequencing
Approximately, 50,000 cells were harvested and used for ATAC-seq 
library preparation as described in the Fast-ATAC protocol (57). 
ATAC-seq libraries were uniquely indexed with Nextera PCR Primers 
and amplified with 9 to 12 cycles of PCR amplification. Amplified 
DNA fragments were purified with 0.8:1 ratio of Agencourt AMPure 
XP (Beckman Coulter) to sample. Libraries were quantified by Qubit, 
and size distribution was inspected by Bioanalyzer (Agilent Genomic 
DNA chip, Agilent Technologies). All libraries were pooled to 10 nM 
per sample before sequencing.
Promoter capture Hi-C
In situ Hi-C was performed as described previously (58). Briefly, 
5 million decidualized cells were treated with formaldehyde 1% to 
cross-link interacting DNA loci. Cross-linked chromatin was treated 
with lysed and digested with MboI endonuclease (New England 
Biolabs). Subsequently, the restriction fragment overhangs were 
filled in and the DNA ends were marked with biotin-14-dATP (Life 
Technologies). The biotin-labeled DNA was sheared and pulled down 
using Dynabeads MyOne Stretavidin T1 beads (Life Technologies, 
65602) and prepared for Illumina paired-end sequencing. The in 
situ Hi-C library was amplified directly off of the T1 beads with nine 
cycles of PCR using Illumina primers and protocol (Illumina, 2007). 
Promoter capture was performed as described previously (39). The 
Hi-C library was hybridized to 81,735 biotinylated 120-bp custom 
RNA oligomers (Custom Array) targeting promoter regions (four 
probes/RefSeq transcription start sites). After hybridization, post-
capture PCR was performed on the DNA bound to the beads via 
biotinylated RNA.
Differential expression
Read counts per gene were calculated with Salmon (59) version 0.12.0 




Estimated counts were used in exploratory analysis (transformed 
with DESeq2’s rlog function) and in DESeq2 (25) version 1.24.0 to 
identify differentially expressed genes (adjusted P ≤ 0.05 and absolute 
fold change of ≥1.2). After observing that replicates for each cell 
lines clustered together, we pooled reads for each cell line, combining 
three decidualization experiments in each sample. We then performed 
a paired analysis to obtain genes that were differentially expressed 
between untreated and decidualized samples. The six samples clustered 
by treatment and by cell line and analysis with svaseq (60) showed 
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that the two surrogate variables identified correlated with cell line, 
and therefore, a paired analysis was enough to correct the data.
Peak calling
ATAC-seq reads were trimmed with cutadapt and aligned with 
bowtie2 (61) version 2.3.4.1. Reads with mapping quality lower than 
10 were discarded. ChIP-seq reads were also aligned with bowtie2. 
Peaks were called using MACS2 (62) version 2.1.2 with param-
eters --llocal 20000 --shift -100 --extsize 200 -q 0.05 for ATAC-seq 
and default parameters for ChIP-seq. Peaks overlapping coordi-
nates blacklisted by Kundaje were excluded (http://hgdownload.
cse.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeMapability/
wgEncodeDacMapabilityConsensusExcludable.bed.gz).
Differential ATAC-seq and ChIP-seq peaks
Similarly to RNA-seq, we pooled reads from replicates for each cell 
line. We called peaks for each of the six samples using MACS2 and 
converted peak coordinates into 100-bp contiguous bins. Bins cov-
ered by less than 60% of their extension were excluded. To identify 
reproducible peaks, we only kept bins that were present in at least 
two of the three cell lines in each condition, allowing for condition- 
specific peaks. See table S7 for an assessment of the contribution of each 
cell line to the universe of peaks obtained. We then merged all adjacent 
bins, expanding them back into longer peaks. We counted the number 
of reads in all peaks and in all samples and compared the read counts 
using DESeq2 (adjusted P < 0.05 and absolute fold change >1.2).
Statistical analysis of the frequencies of differential peaks 
near differentially expressed genes
The P values in Fig. 2B were calculated with a chi-square test of the 
number of peaks with increased or decreased numbers of reads ob-
served and an expected probability based on the number of peaks in 
each category for each dataset. Bonferroni correction was performed 
to correct for multiple testing.
Transcription factor ChIP-seq
ChIP-seq reads were downloaded from National Center for Bio-
technology Information Gene Expression Omnibus and processed 
locally. HOMER 4.9 (63) was used to call peaks for the following 
samples: PGR (GSE94038); NR2F2 (GSE52008); FOSL2 (GSE94038), 
FOXO1 (GSE94037); and NR2F2 input (GSE52008); and FOXO1, 
PGR, and FOSL2 input (GSE94038).
Overlap between ATAC-seq and ChIP-seq peaks
Reproducible peaks were converted into 100 bp bins and those 
with >60% of their extension covered by a peak was retained. Com-
mon bins were counted, and the number of counts was plotted with 
UpSetR 1.4.0.
Motif enrichment
We used HOMER 4.9 to identify DNA binding motifs enriched in 
peaks with parameters -len 8,10,12 -size 200 -mask.
Enrichment of overlap between peaks
Enrichment was calculated as the observed number of overlapping 
peaks divided by the expected number of overlapping peaks using 
bedtools intersectBed with a 1 bp minimum. The expected number 
of overlapping peaks was obtained by averaging 100 random sam-
ples of peaks with bedtools shuffle excluding gaps annotated by the 
University of California, Santa Cruz Genome Browser (64). While 
shuffling peaks does not account for mapping and other biases that 
make peak locations nonuniform and may result in overestimation 
of enrichment, our results are limited to comparisons between en-
richments, which should cancel any biases.
Hi-C interaction calling
We used HiCUP v0.5.9 (65) to align and filter Hi-C reads. HiCUP 
used bowtie2 version 2.2.3 to align reads. Unique reads were used as 
input by CHiCAGO (66) version 1.2.0, and significant interactions 
were called with default parameters. We only kept interactions 
identified by CHiCAGO that were in cis and with an end located at 
least 10 kb from a capture probe.
Pairing differential peaks with putative target genes
To pair peaks using pcHi-C, significant interactions identified by 
CHiCAGO that overlapped an ATAC-seq or ChIP-seq peak and were 
less than 300 kb away from a promoter were used. We chose 300 kb be-
cause the mean distance between interacting promoters and other re-
gions was 280 kb (median, 200 kb). To pair peaks to the nearest gene, 
BEDTools closest -t first -d was used to find the gene closest to a peak, up 
to 300 kb away. To pair peaks to a random gene, all genes up to 300 kb 
from a peak were selected and one gene was randomly assigned to each 
peak. For each of these sets of pairs, we calculated the fraction of peak/
gene pairs that had the same direction of change according to differential 
read count analysis with DESeq2, of the total number of peak/gene pairs. 
Only genes expressed at >1 transcript per million across all samples were 
used in the nearest and random gene assignments.
P values were calculated with a chi-square test comparing the 
number of cases in the matched and unmatched categories observed 
in the random set (average from 200 iterations) and in the two peak/
gene pairing methods: nearest gene and pcHi-C interactions.
Gestational duration GWAS
The GWAS results used in this study was an extension of our previously 
published results (5). Like our previous study, we used summary 
results from 23andMe, which were obtained from GWAS of gesta-
tional duration in 42,121 mothers of European ancestry. In addition, 
we performed GWA analyses in 14,263 European mothers from six 
academic datasets. To increase the power of GWA discovery, we per-
formed meta-analysis between the results from 23andMe and the 
results from the six datasets. See the Supplementary Materials for a 
full description of the GWAS.
GWAS enrichment analysis with S-LDSC
We assessed how much of the heritability of gestational duration is 
contained within ATAC-seq, H3K4me1, H3K4me3, H3K27ac, and 
pcHi-C peaks using S-LDSC (41). S-LDSC is a generalization of LD 
score regression, a method for estimating the heritability of a trait 
using SNP-level GWAS summary statistics and SNP-level estimates 
of the amount of genetic variation tagged at each variant, known as 
LD scores. Under the LD score regression model, the expected value 
of the GWAS summary statistic for a variant (specifically, the ex-
pected value of the 2 statistic) is a linear function of the LD score at 
that site, and h2, the per-SNP heritability, and a an intercept parameter. 
Under the S-LDSC model, rather than estimating a single per-SNP 
heritability parameter, a parameter is estimated for each of several 
functional annotations. In a standard S-LDSC analysis, user-provided 
annotations are combined with a “baseline” set of genomic annotations 
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from publicly available datasets. For this analysis, LD scores were 
calculated using the peaks identified as reproducible across either 
treated or untreated samples as annotations and the genotype data 
from the European individuals from phase 3 of the 1000 Genomes 
project (obtained from the Price Lab website: https://alkesgroup.
broadinstitute.org/LDSCORE/) as a reference LD panel, using only 
the HapMap3 SNP list (also from the Price lab website). S-LDSC 
was performed on the gestational duration GWAS using the 
endometrial-tissue derived LD scores and the baseline LD scores 
contained in version 2.2 of the LD score regression baseline LD model. 
We include all annotations from the baseline LD model except those 
“flanking” annotations. This resulted in a total of 64 baseline anno-
tations used in our S-LDSC analysis.
Fine-mapping GWAS loci associated with gestational length
Fine mapping proceeded in three stages. In the first stage, we parti-
tioned the genome into 1703 regions approximately independent 
regions using breakpoints derived by Berisa et al. (40). Next, we 
constructed an SNP-level prior probability of being causal variant, 
informed by the functional genomic data that we collected. We used 
a Bayesian hierarchical model [TORUS (42)]. TORUS takes as input 
GWAS summary statistics and genomic annotations and estimates 
the extent to which SNPs with functional genomic annotations are 
likely to be causal for a trait of interest. Specifically, under TORUS, 
each SNP has a small prior probability of being a causal variant, which 
is a logistic function of the annotations of the SNP. Then, TORUS 
estimates the parameters of this logistic function using genome-wide 
summary statistics. Once these parameters are estimated, each SNP 
will have a prior causal probability based on its unique functional 
annotations. We ran TORUS with the gestational age GWAS sum-
mary statistics and the reproducible H3K27ac and H3K4me1 peaks 
from the treated samples along with the pcHi-C contact regions to 
obtain an SNP-level prior.
Last, fine mapping was performed using a summary statistics- based 
version of the “sum of single effects” model (43) using 1000 Genome as 
reference panel. SuSiE (as implemented in the R package “susieR”) was 
run on the 10 regions believed to have one or more causal variants 
with an FDR of 0.1 as estimated by TORUS. For each region, SuSiE 
was run with a uniform prior (default setting of SuSiE) and with 
an informed prior learned by TORUS. The parameter L of SuSiE 
(maximum number of causal variants) is set at 1 when running 
SuSiE (67, 68).
SNPs in Epigenome roadmap histone modification peaks
H3K27ac, H3K4me1, and H4K4me3 histone modification peak 
coordinates were downloaded from the Epigenome Roadmap data 
website, and bedtools intersect was used to find peaks that overlapped 
SNPs coordinates.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/6/49/eabc8696/DC1
View/request a protocol for this paper from Bio-protocol.
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